Increased serum phosphodiesterase activity in women with pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue 5, 2006, Pages 577-579

  Pinheiro Da Costa, B E ^a   Scocco, C ^b   Poli De Figueiredo, C E ^a   Guimaraes J A ^b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Nitric oxide; Phosphodiesterase; Pre eclampsia; Pregnancy

Indexed keywords

CREATININE; CYCLIC GMP; NITRIC OXIDE; PHOSPHODIESTERASE; THYMIDINE PHOSPHATE; THYMIDINE PHOSPHATE 4 NITROPHENYL ESTER; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ARTICLE; BIRTH WEIGHT; BRAZIL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; HUMAN; MATERNAL AGE; PATHOGENESIS; PLACENTA WEIGHT; PREECLAMPSIA; PRIORITY JOURNAL; SERUM; SYSTOLIC BLOOD PRESSURE;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; PHOSPHORIC DIESTER HYDROLASES; PRE-ECLAMPSIA; PREGNANCY;

EID: 33646013295     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.00916.x     Document Type: Article

References (12)

1. Roberts JM Redman CWG. Pre-eclampsia: more than pregnancy induced hypertension. Lancet 1993 341 1447 54.
2. Wareing M Myers JE O'Hara M Kenny LC Warren AY Taggart MJ et al. Effects of a phosphodiesterase-5 (PDE) inhibitor on endothelium-dependent relaxation of myometrial small arteries. Am J Obstet Gynecol 2004 190 268 74.
3. Alexander BT Llinas MT Kruckeberg WC Granger JP. L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension 2004 43 832 6.
4. Germain AM Valdés G Romanik MC Reyes MS. Evidence supporting a beneficial role for long-term L-arginine supplementation in high-risk pregnancies. Hypertension 2004 44 e1.
5. Facchinetti F Longo M Piccinini F Neri I Volpe A. L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Investig 1999 6 202 7.
6. Grunewald C Carlstrom K Kumliem G Ringqvist A Lundberg J. Exhaled oral and nasal nitric oxide during L-arginine infusion in preeclampsia. Gynecol Obstet Invest 1998 46 232 7.
7. Downing JW Ramasubramanian R Johnson RF Minzter BH Paschall RL Sundell HW et al. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia. Med Hypotheses 2004 63 1057 64.
8. Teran E Escudero C Vivero S Enriquez A Calle A. Intraplatelet cyclic guanosine-3′,5′-monophosphate levels during pregnancy and preeclampsia. Hypertens Pregnancy 2004 23 303 8.
9. Schneider F Lutun P Baldauf JJ Quirin L Dreyfus M Ritter J et al. Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre-eclampsia. Acta Obstet Gynecol Scand 1996 75 40 4.
10. x diet. Am J Physiol 1999 277 F48 57.
11. Yamamoto T Suzuki Y Kojima K Suzumori K. Reduced flow-mediated vasodilatation is not due to a decrease in production of nitric oxide in preeclampsia. Am J Obstet Gynecol 2005 192 558 63.
12. Wareing M Myers JE O'Hara M Baker PN. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab 2005 90 2550 5.